WeForNews | Latest News, Breaking News, News Updates Even passive smoking allied to infertility, early menopause | WeForNews | Latest News, Blogs
Connect with us

Health

Even passive smoking allied to infertility, early menopause

Published

on

no smoking-wefornews
file name

A new study warns that, both active and passive smoking are linked to infertility problems and a hastening of the natural menopause before the age of 50.

High levels of tobacco exposure is associated with the arrival of menopause one to two years earlier in active and passive smokers than among lifetime non-smokers who had not been exposed to passive smoking, the findings showed.

“This is one of the first studies of this size and statistical power to investigate and quantify active and passive smoking and women’s health issues. It strengthens the current evidence that all women need to be protected from active and passive tobacco smoke,” said Danielle Smith from Roswell Park Cancer Institute in New York, and colleagues.

The toxins found in tobacco smoke are known to have various deleterious effects on many aspects of reproduction and to disrupt hormone production and activity, the study explained.

The researchers based their findings on information obtained on lifetime smoking habits, fertility problems, and age at natural menopause provided by more than 93,000 women taking part in the Women’s Health Initiative Observational Study (WHI OS).

All the women had gone through the menopause, and were aged between 50 and 79 when they were recruited to the study between 1993 and 1998.

Analysis of the data showed that tobacco exposure was associated with an increased risk of infertility and earlier menopause.

Compared with never smokers, current or former smoking was associated with 14 percent greater risk of infertility and a 26 percent heightened risk of menopause before the age of 50.

For the highest levels of tobacco use, the menopause arrived almost 22 months earlier for those who said they had started smoking before their 15th birthday and 18 months earlier among those who smoked at least 25 cigarettes a day.

The highest level of passive smoke exposure was associated with the arrival of menopause 13 months earlier than the lowest (zero) level.

wefornews bureau

Health

Congress alleges govt procuring Covid vaccine at inflated prices

The Congress leader said the price of such a vaccine must be cheaper than AstraZeneca-Serum Institute of India’s Covishield.

Published

on

By

Covid 19 Vaccine

New Delhi, Jan 17 : The Congress on Sunday questioned the procurement of Covid vaccines, alleging that the government has procured the vaccines at inflated prices despite the manufacturers claiming they would supply the vaccines without seeking profit.

Congress General Secretary Randeep Singh Surjewala, addressing a press conference, said, “Why should the Modi government pay Rs 95 per dose more to Bharat Biotech for a vaccine that has been developed with the expertise and experience of scientists of government-run ICMR and pay more for a vaccine that has only been tested on 755 individuals and is yet to be cleared after phase-3 trials?”

The Congress leader said the price of such a vaccine must be cheaper than AstraZeneca-Serum Institute of India’s Covishield.

“Why is the price of the vaccine at Rs 1,000 per dose in the open market?” he asked.

Surjewala said, “‘Covishield’ is an AstraZeneca vaccine manufactured by Serum Institute of India. Serum Institute is supplying this vaccine at Rs 200/dose to government. AstraZeneca has committed to supplying the vaccine at no profit while ‘Covaxin’, manufactured by Bharat Biotech, is being supplied at Rs 295/dose. Admittedly, Covaxin has been developed by Bharat Biotech in partnership with Indian Council of Medical Research (ICMR).”

SII CEO Adar Poonawalla had said stated that his company will sell Covishield for Rs 1,000 per dose in open market, that is Rs 2,000 for 2 doses required for every individual.

Surjewala said, “Why should export of vaccine be permitted without immunisation of India’s population? ‘Corona Vaccine For All’ should be the stated policy of Modi government.”

“However, the government’s approach on free vaccination or cost of vaccination, cost to exchequer, profit margins of companies, etc, for India’s 130 crore people is completely opaque and shrouded in secrecy,” he said.

Continue Reading

Health

13 Israelis suffer facial paralysis post inoculation

“For at least 28 hours, I walked around with it (facial paralysis),” one person who had the side effect told Ynet.

Published

on

By

Vaccine

Jerusalem, Jan 17 : At least 13 Israelis suffered mild facial paralysis as a side effect after receiving the first Covid vaccine jabs, the Health Ministry said, adding that the count could be higher.

The officials have raised questions on whether or not to administer the second dose to these individuals the Health Ministry had recommended for the second dose, reported the Jerusalem Post.

“For at least 28 hours, I walked around with it (facial paralysis),” one person who had the side effect told Ynet.

“I can’t say it was completely gone afterwards, but other than that I had no other pains, except a minor pain where the injection was, but there was nothing beyond that.”

As for receiving the second dose, he admits he is undecided, but says that “it is important to note that this is something rare, and I don’t want people to avoid getting vaccinated – it’s important”.

“I recently came across, for example, someone vaccinated who was dealing with paralysis, and decided not to give her a second dose,” Galia Rahav, Director of the Infectious Diseases Unit at Sheba Medical Centre told Ynet.

“It is true that it can be given according to the Health Ministry, but I did not feel comfortable with it.”

She added that, “No one knows if this is connected to the vaccine or not. That’s why I would refrain from giving a second dose to someone who suffered from paralysis after the first dose.”

However, the Health Ministry has assured of the second dose only when the paralysis passes, Ynet reported.

Continue Reading

Cities

Delhi reports 51 cases of minor adverse events post vaccination

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Published

on

By

Covid 19 Vaccine

Hours after the Health Ministry announced on January 16 that India has reported no case of post-vaccination hospitalisation yet, 51 persons complained of minor adverse events in Delhi. Another person developed severe adverse event following immunization and had to be referred to the AEFI centre.

Out of a total of 4,319 healthcare and frontline workers who were vaccinated on Jnauary 16 in the National Capital, two healthcare workers at NDMC’s Charak Palika Hospital reported mild adverse event post-vaccination including mild tightness in the chest. They were kept under observation by AEFI team and discharged 30 minutes later after they felt at ease. The two other cases were reported from Northern Railway Central Hospital, of which one was referred to the AEFI centre, the Delhi government has informed.

As many as 1,91,181 people were vaccinated on day one of India’s first phase of the coronavirus vaccination drive.

Beneficiaries from 11 states and union territories across India received Covishield or Covaxin shots on the first day of the vaccination drive, namely, Assam, Bihar, Delhi, Haryana, Karnataka, Maharashtra, Odisha, Rajasthan, Tamil Nadu, Telangana, and Uttar Pradesh.

Follow our coverage of the coronavirus crisis here

Continue Reading
Advertisement

Most Popular